Form 8-K - Current report:
SEC Accession No. 0001567264-25-000069
Filing Date
2025-07-18
Accepted
2025-07-18 16:18:30
Documents
12
Period of Report
2025-07-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K intensity-20250717.htm   iXBRL 8-K 29466
  Complete submission text file 0001567264-25-000069.txt   152573

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT intensity-20250717.xsd EX-101.SCH 1827
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT intensity-20250717_lab.xml EX-101.LAB 23449
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT intensity-20250717_pre.xml EX-101.PRE 13606
14 EXTRACTED XBRL INSTANCE DOCUMENT intensity-20250717_htm.xml XML 2935
Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41109 | Film No.: 251134727
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)